[Possibility of improvement of new cardiopulmonary bypass technique without heparin].
D001120:Arginine / Q000031:analogs & derivatives; D002315:Cardiopulmonary Bypass / Q000379:methods*; D011464:Epoprostenol / Q000627:therapeutic use / Q000031:analogs & derivatives; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D010875:Pipecolic Acids / Q000627:therapeutic use; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors; D012122:Ventilators, Mechanical
D010875:Pipecolic Acids; D011465:Prostaglandins, Synthetic; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; D011464:Epoprostenol; D013917:Thrombin; C031942:argatroban; C035847:ataprost